Adrenal incidentaloma
Adrenal incidentaloma
Explore linked clinical trials. Standard reference: MESH:M05326999 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ultradian Steroid Rhythms in Adrenal Incidentalomas | Adrenal incidentaloma | Recruiting | Not applicable | 2026-04-23 | NCT07387419 | |
| IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion | Adrenal incidentaloma, Body Weight, Body Weight Changes, Cushing syndrome, Insulin Resistance, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, adrenal gland disorder, adrenal gland hyperfunction, ectopic ACTH secretion syndrome, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, neoplasm, paraneoplastic syndrome | Recruiting | Not applicable | 2026-03-27 | NCT07361874 | |
| Cardiovascular Complications After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors | Adrenal incidentaloma, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, paraganglioma, pheochromocytoma, primitive neuroectodermal tumor | Not yet recruiting | Not stated | 2025-10-01 | NCT07200245 | |
| Artificial Intelligence Used in Screening Adrenal Nodules | Adrenal incidentaloma | Recruiting | Not stated | 2025-09-30 | NCT07198152 | |
| Clinical Outcome of Autonomous Cortisol Secretion in Adrenal Incidentalomas | Adrenal incidentaloma | Active, not recruiting | Not stated | 2025-09-05 | NCT04917757 | |
| Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations | Adrenal incidentaloma, Cushing syndrome, Neoplasms by Site, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, adrenal gland neoplasm, endocrine system disorder, malignant endocrine neoplasm, neoplasm | Recruiting | Not stated | 2025-03-28 | NCT04127552 | |
| Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome | Adrenal incidentaloma, Cushing syndrome, adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder | Recruiting | Phase 4 | 2025-01-30 | NCT06801249 | |
| Association Between Stroke and Adrenal Incidentalomas | Adrenal incidentaloma, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2022-02-14 | NCT05237817 | |
| A Prospective Cohort Study for Patients With Adrenal Diseases | Adrenal incidentaloma, Cushing syndrome, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Paraneoplastic Endocrine Syndromes, adenocarcinoma, adrenal cortex adenoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, carcinoma, ectopic ACTH secretion syndrome, endocrine system disorder, epithelial neoplasm, hyperaldosteronism, malignant endocrine neoplasm, neoplasm, neuroendocrine neoplasm, paraganglioma, paraneoplastic syndrome, pheochromocytoma, primary aldosteronism, primitive neuroectodermal tumor | Enrolling by invitation | Not stated | 2020-03-18 | NCT03474237 |